AJUCOVE Trademark

Trademark Overview

On Wednesday, October 9, 2013, a trademark application was filed for AJUCOVE with the United States Patent and Trademark Office. The USPTO has given the AJUCOVE trademark a serial number of 86086736. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, May 22, 2017. This trademark is owned by Glaxo Group Limited. The AJUCOVE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, and psychiatric related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; vaccines
ajucove

General Information

Serial Number86086736
Word MarkAJUCOVE
Filing DateWednesday, October 9, 2013
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, May 22, 2017
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 18, 2014

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, and psychiatric related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, October 17, 2013
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
GB

Trademark Events

Event DateEvent Description
Monday, May 22, 2017ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, May 22, 2017ABANDONMENT - NO USE STATEMENT FILED
Tuesday, February 14, 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, February 14, 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, November 3, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 2, 2016EXTENSION 5 GRANTED
Monday, October 10, 2016EXTENSION 5 FILED
Monday, October 10, 2016TEAS EXTENSION RECEIVED
Thursday, April 28, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 27, 2016EXTENSION 4 GRANTED
Thursday, April 14, 2016EXTENSION 4 FILED
Thursday, April 14, 2016TEAS EXTENSION RECEIVED
Wednesday, October 21, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 20, 2015EXTENSION 3 GRANTED
Wednesday, September 30, 2015EXTENSION 3 FILED
Wednesday, September 30, 2015TEAS EXTENSION RECEIVED
Saturday, March 28, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, March 27, 2015EXTENSION 2 GRANTED
Friday, February 13, 2015EXTENSION 2 FILED
Friday, March 27, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, February 13, 2015TEAS EXTENSION RECEIVED
Tuesday, August 26, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, August 22, 2014EXTENSION 1 GRANTED
Friday, August 22, 2014EXTENSION 1 FILED
Friday, August 22, 2014TEAS EXTENSION RECEIVED
Tuesday, April 15, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 18, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 18, 2014PUBLISHED FOR OPPOSITION
Wednesday, January 29, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, January 11, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, January 10, 2014ASSIGNED TO EXAMINER
Thursday, October 17, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, October 12, 2013NEW APPLICATION ENTERED IN TRAM

Related Keywords

ajucove pharmaceutical treatment substances disorders preparations diseases gastrointestinal respiratory neurological hepatological